Translating Data into Actionable Insights to Inform your Patient Access Strategy
By Andrew Duncan, SVP of Business Operations, Pricing & Strategic Finance Pharmaceutical companies are embracing big data initiatives to drive their business objectives. For brand teams, data is valuable only when they have the right data to make informed decisions that improve access to their retail and specialty-lite therapies. Life science companies that invest in capabilities to capture, strategically analyze, and draw actionable insights from the most relevant data will realize better brand outcomes